We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03284424
Brief Title: Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)

First Submitted : September 14, 2017
First Submitted that Met QC Criteria : September 14, 2017
First Posted : September 15, 2017

Results First Submitted : September 14, 2021
Results First Posted with QC Comments : October 12, 2021
Results First Submitted that Met QC Criteria : October 21, 2021
Results First Posted : November 19, 2021

Certification/Extension First Submitted : July 14, 2021
Certification/Extension First Submitted that Met QC Criteria : October 21, 2021
Certification/Extension First Posted : November 19, 2021

Last Update Submitted that Met QC Criteria : June 30, 2022
Last Update Posted : July 1, 2022